Skip to main content
Gabriel Uwaifo, MD, Endocrinology, Springfield, IL

Gabriel Ikponmosa Uwaifo MD FACP, FACE, FTOS, FRSM, DABOM

Adrenal Disease, Diabetes, Lipid Metabolism, Obesity


- Clinical Professor of Medicine, Endocrinology, Diabetes, Metabolism, Nutrition and Weight Management. - Attending Clinical and Research Endocrinologist. - Senior Clinical Research Scientist.

Join to view full profile
  • 751 N Rutledge StSte 1700Springfield, IL 62702

  • Phone+1 217-545-8000

  • Fax+1 217-545-1229

Dr. Uwaifo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Gabriel Uwaifo, MD, is an endocrinologist based in Springfield, IL, with clinical expertise in adrenal disease, prediabetes, diabetes, lipid metabolism, clinical hypertension, male and female reproductive medicine, pituitary disease, thyroid disease, nutrition, weight management and obesity. He completed his residency in internal medicine at the University of Connecticut and a clinical and research fellowship in endocrinology, diabetes, and metabolism at the National Institutes of Health Clinical Center. He is presently a Clinical Professor at Southern Illinois University School of Medicine and Program director of the Endocrinology Fellowship program at the same program. Dr. Uwaifo is an experienced clinical internist, endocrinologist, medical bariatrician and diabetologist and an experienced clinical trialist who has served as PI or substantive CO-I on numerous industry and NIH sponsored clinical trials. He has authored over 100 peer reviewed clinical publications and several book chapters. He has also served as chief editor of a textbook on the human hypothalamus. He has several professional fellowships and several other honors in his field.

Clinical Expertise

  • Bariatric medicine, Morbid obesity, Obstructive sleep apnea, Gestational diabetes, Diabetes, Non-alcoholic steatohepatitis, Cushing syndrome, Clinical research, Diabetic complications, Thyroid disease, Type II diabetes, Type I diabetes, Pre-diabetes, Endocrine hypertension, Anti-Obesity Agents, Bariatrics, Diabetes detection and prevention, Diabetes devices, Diabetes therapeutics, Hypertension therapeutics, obesity

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 1995 - 1999
  • University of Ibadan
    University of IbadanClass of 1990

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2023 - 2029
  • LA State Medical License
    LA State Medical License 2010 - 2027
  • MS State Medical License
    MS State Medical License 2007 - 2027
  • DC State Medical License
    DC State Medical License 1999 - 2008
  • MD State Medical License
    MD State Medical License 2005 - 2007
  • CT State Medical License
    CT State Medical License 1995 - 1999
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • Obesity Medicine
    American Board of Obesity Medicine Obesity Medicine
  • Clinical Hypertension Specialist
    American Society of HypertensionClinical Hypertension Specialist

Awards, Honors, & Recognition

  • Fellow of the Royal Society of Medicine Royal Society of Medicine, 2022
  • FACP American College of Physicians
  • FTOS The Obesity Society, 2018

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Pituitary Tumors Case Reports 
    ENDO 2019 - New Orleans, LA - 3/23/2019

Press Mentions

  • A Monoclonal Antibody Shows Promise for Weight Loss in Obese People with Diabetes
    A Monoclonal Antibody Shows Promise for Weight Loss in Obese People with DiabetesMarch 3rd, 2022
  • Analysis Group Study Fills Research Gap on Inpatient Management of Hyperkalemia and Subsequent Readmissions
    Analysis Group Study Fills Research Gap on Inpatient Management of Hyperkalemia and Subsequent ReadmissionsJuly 20th, 2021

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: